Thai luxury property developer V Property Development to launch IPO in 2019
The proceeds from IPO will be used for new developments in luxury condominium along Sukhumvit Road and the BTS green line.
Thai luxury property developer V Property Development Co is accelerating its business growth as it prepares to launch an initial public offering (IPO) on the Stock Exchange of Thailand by 2019, according to Bangkok Post’s report.
It has appointed AEC Securities as a financial advisor to the IPO.
Chief executive Porchchai Lertananchoke told the media that it targets to have the project orders worth 8 billion baht ($251.4 million) before launching the IPO.
It projects its pre-sales will reach 3.5 billion baht ($110 million) in the first half of this year, while it reported total revenue of 3 billion baht ($94.3 million) in 2017, up 90 per cent from the previous year.
The proceeds from IPO will be used to support its business growth and new developments in luxury condominium sector in the future, he said. Its main strategy is to focus on developing the projects along Sukhumvit Road and the BTS green line.
According to the DD Property Market Outlook 2018 report, demand for new releases will move into an upward trend in 2018 thanks to rising consuming spending, the economic recovery, the expansion of mass transit lines, and government infrastructure projects along the Eastern Economic Corridor.
“On the supply side, 2018 may see even more projects from developers compared to 2017, so the real estate market is forecast to show signs of improved health this year,” said Kamolpat Swaengkit, Country Manager for DDproperty.
The report cited that condominiums remain the top pick for people attracted to an urbanized lifestyle. The DDproperty Property Index showed condominiums had the highest price index growth in the third quarter of 2017, compared to single-detached houses and townhouses, reflecting increased demand.
DEALSTREETASIA Pte. Ltd. is a news and intelligence platform providing reports on investments, mergers, acquisitions, private equity, venture capital, investment banking and the business of startups across the Asian region.
Economics
Asia’s slow rate of vaccination is a thorn in the region’s economic recovery
Southeast Asia has been hit badly. Daily infections for Indonesia, Thailand, Vietnam are at their worst, on a seven-day moving average. The Philippines and Malaysia are not far off their daily infection peaks reached in the second quarter of 2021.
Last week was tough for the Asia-Pacific region. Many countries responded to stubbornly elevated daily infections by extending or tightening social distancing measures.
(more…)
Tourism
TAT expects 850 billion baht ($25.7 bln) in tourism revenue after successful reopening
The Tourism Authority of Thailand (TAT) has set this year’s revenue target at 850 billion baht, 300 billion of which will come from 3 million international visitors and the remaining 550 billion from the domestic market.
BANGKOK (NNT) – Following the launch of the Phuket Sandbox tourism scheme on July 1st this year, many foreign tourists moved by the warm hospitality of the people of Phuket, are looking forward to visiting other provinces, such as Chiang Mai and Bangkok.
(more…)
Asia’s slow rate of vaccination is a thorn in the region’s economic recovery
Southeast Asia has been hit badly. Daily infections for Indonesia, Thailand, Vietnam are at their worst, on a seven-day moving...
TAT expects 850 billion baht ($25.7 bln) in tourism revenue after successful reopening
The Tourism Authority of Thailand (TAT) has set this year’s revenue target at 850 billion baht, 300 billion of which...
Download 1xBet mobile and play all over the world
Placing profitable bets or playing in a casino is now possible comfortably even without being tied to a computer. It...
3 ways Asia can recover from the COVID-19 pandemic faster
Countries in the East Asia and Pacific region will benefit from cooperation in three major areas: vaccine deployment, reviving sectors...
Thailand’s Vaccine Strategy: What went wrong?
Questions are being asked, and not answered, over the decision to rely almost entirely on Siam Bioscience, a local, palace-owned...